# DeepSeek V4.1 Flash / neu-d02

Original final answer, shared by both scoring rounds.

**Bottom line / recommended next action.** Run a two-stage proposed protocol. **Stage A (calibration pilot):** estimate the unknown parameters—indicator kinetics, imaging-rate adequacy, expression range, neuropil contamination coefficient, motion noise floor, detection thresholds, and fluorescence-to-spike mapping—using simultaneous electrophysiology as ground truth in the target cell type. **Stage B (validation):** apply the frozen calibration to held-out cells/animals and report detection, spike-count error, visual-response tracking, false positives, neuropil sensitivity, and expression-stratified performance. Do not treat GECI fluorescence as an error-free instantaneous spike readout. All experiments below are proposed.

---

## 1. Evidence-to-inference-to-conclusion chain

**Evidence (from fixed packet).**
- **E1.** The indicator improves activity detection and reports somatic and dendritic-spine visual-related signals; figure captions state simultaneous imaging and electrophysiology calibration.
- **E2.** Stated limits: fluorescence reflects calcium dynamics influenced by the indicator and imaging system, not error-free instantaneous spikes; calibration in one cell type cannot be unconditionally extrapolated.
- **E3.** Artefacts include movement, focus drift, background, and neuropil contamination producing behaviour-related false signals.
- **E4.** Indicator kinetics, saturation, or expression level can make the same fluorescence amplitude correspond to different firing.

**Inferences.**
- **I1.** Because GECI signal is indirect and amplitude is ambiguous (**E2, E4**), paired electrophysiology is required as ground truth for spike detection and spike-count calibration.
- **I2.** Because calibration is cell-type specific (**E2**), the target cell type must be calibrated directly; extrapolation from another cell type is not unconditional.
- **I3.** Because movement, focus drift, background, and neuropil can create false behaviour-related signals (**E3**), a structural reference channel, 3D motion estimation, neuropil controls, and movement controls are necessary.
- **I4.** Because expression and saturation change the fluorescence-to-firing relationship (**E4**), expression-level checks and saturation checks must be part of calibration and validation.
- **I5.** Because visual responses can be confounded by movement/neuropil artefacts (**E3**), visual-response tracking must be paired with electrophysiology and blank/movement controls.

**Conclusion.** The proposed protocol should combine: simultaneous GECI imaging + electrophysiology + structural reference channel + visual stimulation + movement/neuropil controls; target-cell-type calibration; explicit detection and false-positive reporting; expression checks; and held-out validation. Inference should be probabilistic, not treated as instantaneous spike truth.

---

## 2. Scope, assumptions, and unreported parameters

**Available per packet.** Genetically encoded calcium indicator; simultaneous electrophysiology; structural reference channel; visual stimulation; movement and neuropil controls.

**Unavailable and therefore to be calibrated, not assumed.** Exact indicator identity; expression level; spike numbers; imaging rates; analysis thresholds. The protocol below specifies calibration procedures for these.

**Assumptions.** Proposed experiments assume synchronizable electrophysiology and imaging timestamps, identifiable target cell type, stable structural reference channel, and ability to present controlled visual stimuli with blank and movement epochs.

**All experiments are proposed.**

---

## 3. Proposed operational protocol

### Stage 0. Preparation and quality checks

**Proposed Experiment P0: pilot calibration recording.**
- Prepare target cell type with GECI and structural reference channel. Confirm expression qualitatively.
- Establish simultaneous electrophysiology and imaging. Confirm spike isolation or whole-cell stability, as appropriate.
- Acquire structural z-stack at start and end; acquire GECI and structural channels during spontaneous and visually evoked periods.
- Quality checks:
  - Electrophysiology: stable baseline, identifiable spikes, no drift in spike amplitude, stable recording.
  - Imaging: no saturation, no obvious photobleaching, stable focus, no gross movement.
  - Structural channel: visible landmarks, sufficient contrast for registration.
  - GECI: baseline fluorescence present; dynamic range not saturated.
- If any check fails, correct before calibration. Record all checks.

**Purpose.** P0 estimates unknown parameters: imaging rate adequacy, motion noise floor, expression range, neuropil contamination coefficient, detection threshold candidates, and approximate fluorescence-to-spike relationship.

---

### Stage 1. Independent units, allocation, and blinding

**Independent units.**
- Biological unit: animal.
- Cellular unit: recorded cell within animal.
- Trial unit: visual stimulus or spontaneous epoch within cell.
- Event unit: spike or inferred calcium event within trial.
- Use nested models: events within trials within cells within animals.

**Allocation.**
- Proposed: split animals or cells into **calibration set** and **validation set**. Prefer animal-level split to avoid leakage. If animal-level split is not feasible, use cell-level split with held-out trials.
- Randomize visual stimulus order and interleave blank and movement epochs.
- Assign some cells to low/high expression strata if expression varies.

**Blinding.**
- Imaging analyst blind to electrophysiology when selecting ROIs and processing GECI.
- Electrophysiology analyst blind to imaging when spike-sorting and scoring visual responses.
- ROI selection based on structural channel before functional analysis to avoid circular selection of responsive cells.
- Pre-register analysis plan, thresholds, and acceptance criteria before validation.

---

### Stage 2. Intervention and sampling

**Proposed Experiment P1: paired calibration in target cell type.**
- Simultaneously record electrophysiology and GECI imaging in target cell type.
- Present visual stimuli with known timing, including:
  - repeated visual trials,
  - blank/no-stimulus trials,
  - movement-only epochs (if movement control available),
  - spontaneous epochs.
- Record electrophysiology continuously to define spike times and counts.
- Record structural channel simultaneously or interleaved.
- Sample across a range of firing rates and expression levels. If controlled spike counts are needed, propose current injection or graded sensory drive to evoke defined spike trains while imaging; electrophysiology still provides the counted spikes.
- Do not assume spike numbers. Use electrophysiology to count spikes.

**Proposed Experiment P2: validation cohort.**
- Repeat P1 in held-out cells/animals without changing calibration parameters.
- Use same stimulus and movement/blank controls.
- Apply frozen calibration and thresholds from Stage A.

**Sampling notes.**
- Include no-spike periods identified by electrophysiology for neuropil and false-positive estimation.
- Include high-firing periods to test saturation.
- Include low- and high-expression cells to test expression dependence.

---

### Stage 3. Measurements

**Structural reference channel.**
- Acquire z-stack and time series.
- Use structural channel for:
  - ROI definition,
  - 3D motion estimation,
  - focus drift detection,
  - expression/health proxy if independent structural marker,
  - validation of motion correction.

**Three-dimensional motion estimation.**
- Estimate rigid transform (x, y, z) and, if needed, non-rigid deformation from structural channel.
- Apply transform to GECI channel.
- Validate residual motion using structural landmarks after correction.
- Estimate motion noise floor from stationary periods. Reject frames or epochs above calibrated noise floor.
- If volumetric imaging is unavailable, estimate z-drift from structural focus metrics and report limitation.

**GECI measurements.**
- Raw fluorescence, background ROI, neuropil annulus, ΔF/F or equivalent.
- Neuropil contamination coefficient estimated from no-spike periods.
- Expression proxies: structural intensity, GECI baseline F0, maximum evoked ΔF/F, dynamic range.

**Electrophysiology measurements.**
- Spike times, spike counts, firing rate, burst structure.
- Visual response ground truth: spike count in stimulus window vs blank.
- Cell type and recording quality.

**Visual-response tracking.**
- Stimulus timing, trial type, eye/pupil or locomotion if available.
- Pair stimulus times with electrophysiology and imaging frames.
- Track inferred visual responses against electrophysiology-defined visual responses.

**Paired ground truth.**
- Same cell, same trial, same time. Synchronize clocks. Pair electrophysiology spikes with imaging frames and visual stimulus events.

---

### Stage 4. Controls

**Movement control.**
- Present movement without visual stimulus. Compare GECI signal with electrophysiology. Any GECI event without electrophysiological spike is a candidate false positive.

**Neuropil control.**
- Define neuropil annulus around ROI and acellular/background ROI.
- Estimate contamination by regressing ROI fluorescence on neuropil during electrophysiology-defined no-spike periods.
- Correct: ROI_corrected = ROI_raw − α × neuropil, where α is calibrated.
- Sensitivity analysis: vary α over a plausible range and recompute detection/false-positive metrics.

**Focus drift control.**
- Monitor structural channel z-position. Reject or correct epochs with drift beyond calibrated noise floor.

**Background control.**
- Subtract acellular background. Check for camera offset and autofluorescence.

**Expression control.**
- Stratify cells by structural intensity and GECI baseline. Test whether calibration slope, detection, and false positives vary by expression.

**Saturation control.**
- Use high-firing epochs to test nonlinearity. If saturation occurs, restrict inference to non-saturated range or exclude.

**Kinetics control.**
- Estimate fluorescence impulse response from paired spike/fluorescence data. Use it in detection or deconvolution; report estimated rise/decay times.

---

### Stage 5. Calibration procedures for unknown parameters

**Imaging rate.**
- Proposed: pilot at multiple rates if possible. Choose rate where detection metrics plateau and kinetics are adequately sampled. If only one rate is available, report it and treat rate-dependent limits as uncertainty.

**Analysis thresholds.**
- Use electrophysiology ground truth to construct ROC curves for event detection.
- Choose threshold that achieves the study’s pre-specified false-positive rate or precision target. If target not yet defined, define it after pilot calibration and before validation.

**Spike-count calibration in target cell type.**
- For each cell, pair fluorescence with electrophysiology spike counts.
- Fit a model mapping fluorescence (or deconvolved event rate) to spike count. Proposed models: linear, nonlinear, or GLM; choose by held-out performance.
- Validate on held-out trials. Report slope, offset, correlation, error, and limits of agreement.
- Do not extrapolate across cell types without new calibration.

**Neuropil contamination coefficient.**
- Estimate α from no-spike periods. Vary α for sensitivity. If detection metrics change materially, use local correction, smaller ROI, or model neuropil as a covariate.

**Motion thresholds.**
- Estimate residual motion noise floor from stationary structural-channel periods. Set rejection threshold from that noise floor. Calibrate rather than assume.

**Expression-level checks.**
- Measure structural intensity and GECI baseline. Test correlation with calibration slope and detection.
- If expression varies, include as covariate or stratify. If too low or saturated, exclude or titrate expression.

**Detection and false-positive definitions.**
- Detection: inferred calcium event or inferred spike above threshold.
- True positive: inferred event paired with electrophysiology spike.
- False positive: inferred event without electrophysiology spike.
- False-positive visual response: inferred visual response during blank or movement-only epoch without electrophysiology response.
- Report false positives per minute, false discovery rate, precision, recall, and ROC/AUC.

---

### Stage 6. Analysis

**Preprocessing.**
- 3D motion correction using structural channel.
- ROI extraction from structural channel.
- Background subtraction and neuropil correction.
- ΔF/F or equivalent normalization.
- Timestamp alignment.

**Calibration.**
- Fit per-cell and pooled target-cell-type fluorescence-to-spike mapping.
- Estimate kinetics kernel.
- Freeze thresholds and model parameters before validation.

**Detection metrics.**
- TP, FP, FN.
- Precision, recall, F1.
- False positive rate per minute.
- False discovery rate.
- ROC/AUC across thresholds.

**Spike-count metrics.**
- Correlation between inferred and electrophysiological spike counts.
- RMSE, bias, slope, limits of agreement.
- Performance across firing-rate range and expression strata.

**Visual-response metrics.**
- Compare inferred vs electrophysiological visual response.
- Report false positives during blank and movement-only epochs.
- Track reliability across trials.

**Neuropil sensitivity.**
- Recompute detection and false-positive metrics across α range.
- Report whether conclusions are sensitive to neuropil correction.

**Expression analysis.**
- Stratify by structural intensity and GECI baseline.
- Test interaction with calibration and detection.

**Statistics.**
- Use mixed-effects models with animal and cell random effects.
- Report confidence intervals.
- Account for nesting and repeated measures.

---

### Stage 7. Acceptance and stopping criteria

**Quality gates.**
- Stable electrophysiology.
- No saturation or photobleaching beyond calibrated tolerance.
- Residual motion at or below calibrated noise floor.
- Neuropil sensitivity reported.
- Expression range documented.

**Calibration acceptance.**
- Held-out validation performance meets pre-specified tolerance. If tolerance not yet known, define it from pilot calibration before validation.
- Spike-count calibration stable across held-out trials.
- Detection and false-positive metrics reported with uncertainty.

**Neuropil acceptance.**
- Detection/false-positive metrics change less than pre-specified tolerance across α range. If not, report limitation or refine correction.

**Expression acceptance.**
- Adequate dynamic range; no strong expression-dependent bias. If bias exists, report and covary.

**Stopping.**
- Use sequential or power-based stopping. Determine required n via pilot. Stop when confidence intervals for key metrics are within pre-specified precision or when additional units do not materially change estimates.
- If criteria fail, troubleshoot before expanding.

---

### Stage 8. Troubleshooting

| Problem | Check | Proposed action |
|---|---|---|
| High motion | Structural channel residual | Improve fixation; use non-rigid correction; reject frames; recalibrate noise floor |
| Focus drift | Structural z-stack | Re-focus; discard drifted epochs; use z-correction |
| Neuropil contamination | Annulus vs ROI; no-spike regression | Smaller ROI; local subtraction; model neuropil; report sensitivity |
| Low expression | Structural intensity; GECI baseline | Titrate expression; exclude low cells; stratify |
| Saturation | High-firing epochs | Exclude saturated cells; restrict range; reduce expression |
| Ephys instability | Spike amplitude, baseline | Re-pair; check seal; discard unstable recordings |
| False positives | Blank/movement epochs | Adjust threshold; include movement covariates; use ephys-guided training |
| Kinetics mismatch | Impulse response estimate | Deconvolve; use GLM; increase imaging rate if possible |
| Visual-response false positives | Blank vs stimulus | Require ephys confirmation; use movement controls; report separately |

---

## 4. Alternatives and limits

**Alternatives.**
- If structural channel is not independent, use interleaved acquisition or sequential structural/functional blocks.
- If simultaneous electrophysiology is not possible for all cells, calibrate on a paired subset and validate on held-out paired subset; report extrapolation limits.
- If controlled spike counts are not feasible, use electrophysiology-counted spikes as ground truth across observed range.
- If neuropil contamination cannot be removed, model it explicitly and report sensitivity.
- If expression varies widely, use stratified calibration or per-cell calibration.

**Limits.**
- Calibration in one cell type cannot be unconditionally extrapolated (**E2**).
- Fluorescence reflects calcium dynamics influenced by indicator and imaging system, not error-free instantaneous spikes (**E2**).
- Indicator kinetics, saturation, and expression can make the same fluorescence amplitude correspond to different firing (**E4**).
- Movement, focus drift, background, and neuropil can produce behaviour-related false signals (**E3**).
- The proposed protocol reduces but does not eliminate false positives. Inference should be reported as probabilistic, with detection thresholds, false-positive rates, expression strata, neuropil sensitivity, and cell-type-specific calibration all made explicit.

**Conclusion.** The recommended next action is to run the proposed Stage A calibration pilot in the target cell type with simultaneous electrophysiology, structural reference channel, 3D motion estimation, neuropil and movement controls, and visual stimulation; then freeze parameters and run Stage B held-out validation. Report detection, false positives, spike-count error, expression dependence, and neuropil sensitivity rather than treating GECI fluorescence as direct spike truth.
